Carboplatin (Carboplatin Accord) Inj 10 mg per ml, 45 ml vial: Supply issue

Supply issue Active

The supplier is out of stock of Carboplatin Accord (Pharmacode: 2678926).

4 March 2025 Update

The supplier advises that the resupply date has moved out again. The Carboplatin Accord should be available again by mid-to-late March. There is enough stock of the alternative to ensure people can continue to access treatment until the Accord stock is available again.

Affected product

The supplier is out of stock of Carboplatin Accord. There may still be some stock in the supply chain. 

  • Brand: Carboplatin Accord
  • Pharmacode: 2678926
  • Subsidy: $25.73
  • Measure / Qty: per 1

Schedule listing for carboplatin(external link)

HML listing for carboplatin(external link)

Alternative listed

We listed an alternative from 1 February 2025 to ensure people can continue to access this medicine. It has arrived in New Zealand and should be available to order. This brand is not approved by Medsafe so will need to be prescribed and dispensed in line with section 29 of the Medicines Act.

  • Brand: DBL Carboplatin S29
  • Pharmacode: 2698943
  • Subsidy: $25.73
  • Measure / Qty: per 1

Prescribing and supplying an unapproved medicine

Section 29 of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – such as, a doctor. 

We have developed a flier to support conversations with people who take this medicine

We know supplying a medicine under section 29 is not ideal. In this case, however, this will allow patients to be able to access an appropriate treatment. 

We apologise for any inconvenience this causes. 

Advice for prescribing under section 29 – BPAC website(external link) 

Prescriber and pharmacist requirements for section 29 medicines – Medsafe website (external link)

Medsafe’s section 29 Declaration / Notification Form [DOC](external link)

What patients need to know about unapproved medicines – Healthify website(external link)

Expected resupply

The supplier advises that Carboplatin Accord should be mid to late March 2025.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)